Free Trial
NASDAQ:ICCM

IceCure Medical (ICCM) Stock Price, News & Analysis

IceCure Medical logo
$1.03 +0.02 (+1.98%)
Closing price 04:00 PM Eastern
Extended Trading
$1.03 0.00 (0.00%)
As of 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About IceCure Medical Stock (NASDAQ:ICCM)

Key Stats

Today's Range
$1.00
$1.03
50-Day Range
$0.92
$1.15
52-Week Range
$0.48
$1.66
Volume
280,178 shs
Average Volume
486,411 shs
Market Capitalization
$60.46 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$2.50
Consensus Rating
Strong Buy

Company Overview

IceCure Medical Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
46th Percentile Overall Score

ICCM MarketRank™: 

IceCure Medical scored higher than 46% of companies evaluated by MarketBeat, and ranked 620th out of 937 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    IceCure Medical has received a consensus rating of Strong Buy. The company's average rating score is 3.50, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    IceCure Medical has only been the subject of 1 research reports in the past 90 days.

  • Read more about IceCure Medical's stock forecast and price target.
  • Earnings Growth

    Earnings for IceCure Medical are expected to grow in the coming year, from ($0.28) to ($0.25) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of IceCure Medical is -3.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of IceCure Medical is -3.68, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    IceCure Medical has a P/B Ratio of 8.58. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about IceCure Medical's valuation and earnings.
  • Percentage of Shares Shorted

    0.84% of the float of IceCure Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    IceCure Medical has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IceCure Medical has recently increased by 17.61%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    IceCure Medical does not currently pay a dividend.

  • Dividend Growth

    IceCure Medical does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.84% of the float of IceCure Medical has been sold short.
  • Short Interest Ratio / Days to Cover

    IceCure Medical has a short interest ratio ("days to cover") of 0.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in IceCure Medical has recently increased by 17.61%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    IceCure Medical has a news sentiment score of 0.82. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 3 news articles for IceCure Medical this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, IceCure Medical insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 2.44% of the stock of IceCure Medical is held by insiders.

  • Percentage Held by Institutions

    Only 0.62% of the stock of IceCure Medical is held by institutions.

  • Read more about IceCure Medical's insider trading history.
Receive ICCM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for IceCure Medical and its competitors with MarketBeat's FREE daily newsletter.

ICCM Stock News Headlines

IceCure Announces Commencement of Rights Offering
IceCure Medical Ltd (ICCM) - Yahoo Finance
The End of Elon Musk…?
The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, and he's been proven right time and time again. And now, while the media focuses on Tesla's "demise," he's uncovered an AI breakthrough that's about to make Elon's doubters eat their words yet again. According to his research, if you listen to the media and miss out on Elon's newest breakthrough, it's going to cost you the fortune of a lifetime.
See More Headlines

ICCM Stock Analysis - Frequently Asked Questions

IceCure Medical's stock was trading at $1.10 at the start of the year. Since then, ICCM shares have decreased by 6.4% and is now trading at $1.03.

IceCure Medical Ltd. (NASDAQ:ICCM) issued its earnings results on Wednesday, May, 28th. The company reported ($0.06) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.08) by $0.02. The firm earned $0.73 million during the quarter, compared to analysts' expectations of $0.75 million. IceCure Medical had a negative trailing twelve-month return on equity of 182.26% and a negative net margin of 467.37%.
Read the conference call transcript
.

Shares of ICCM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that IceCure Medical investors own include Medical Properties Trust (MPW), Realty Income (O), Oxford Square Capital (OXSQ), PayPal (PYPL), A.P. Moller-Maersk (AMKBY), Annaly Capital Management (NLY) and Oxford Lane Capital (OXLC).

Company Calendar

Last Earnings
5/28/2025
Today
7/16/2025
Next Earnings (Estimated)
8/19/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Medical Services
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:ICCM
CIK
1584371
Employees
60
Year Founded
N/A

Price Target and Rating

High Price Target
$2.50
Low Price Target
$2.50
Potential Upside/Downside
+143.9%
Consensus Rating
Strong Buy
Rating Score (0-4)
3.50
Research Coverage
2 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.28)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.32 million
Net Margins
-467.37%
Pretax Margin
-465.45%
Return on Equity
-182.26%
Return on Assets
-112.65%

Debt

Debt-to-Equity Ratio
0.02
Current Ratio
1.89
Quick Ratio
1.48

Sales & Book Value

Annual Sales
$3.29 million
Price / Sales
18.29
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.12 per share
Price / Book
8.54

Miscellaneous

Outstanding Shares
58,700,000
Free Float
57,265,000
Market Cap
$60.17 million
Optionable
Not Optionable
Beta
0.31
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

This page (NASDAQ:ICCM) was last updated on 7/16/2025 by MarketBeat.com Staff
From Our Partners